Galen Institute

Wall Street Journal, April 30, 2014 With the unveiling of the Affordable Care Act's website, the public experienced a painful reminder of the consequences of the government's new authority over health care. While millions signed up for insurance, millions of others abruptly lost their existing coverage and access to their doctors because that coverage didn't fit new ObamaCare … [Read more...] about Scott W. Atlas: The Coming Two-Tier Health System

The Weekly Standard, April 29, 2014 Recent polling conducted by McLaughlin & Associates for the 2017 Project asked Americans, “If you could undo one thing that President Obama has done as president, what would it be?” The choices that the poll provided were “overregulation of the economy,” “high deficit spending,” “tax increases,” “the economic stimulus package,” and “Obamacare.” And the … [Read more...] about Jeffrey Anderson: Obamacare the #1 Thing Americans Would Undo

Obamacare’s defenders are doing their best to sustain a triumphant mood these days. In the wake of the late-March surge in exchange enrollment, many proponents of the law have insisted it can no longer be rolled back. As the president put it in his April 1 Mission Accomplished speech announcing the enrollment figures, “The Affordable Care Act is here to stay.” But just as conservative … [Read more...] about James Capretta and Yuval Levin: The Obamacare Opportunity

Wall Street Journal, April 24, 2014 A new survey demonstrates the Affordable Care Act's negative impact on employment. According to the Journal, "nearly half of small-business owners with at least five employees, or 45% of those polled, said they had had to curb their hiring plans because of the health law, and almost a third—29%—said they had been forced to make staff cuts, according to a U.S. … [Read more...] about James Freeman: The ObamaCare Jobless

The Hill, April 23,  2014 The U.S. Food and Drug Administration is arguably the most important regulatory agency in the country—regulating everything from the safety of imported seafood to the latest medicines developed for cancer and Parkinson’s. Yet when things go well, FDA Commissioner Margaret Hamburg typically hears little praise from Congress and the media. But when crisis—real or … [Read more...] about Paul Howard: FDA, measure (and improve) thyself

The Weekly Standard, April 21, 2014 Since Obamacare “hit” its “enrollment” “target,” Democrats, liberals, and their friends in the press have enjoyed some old-fashioned taunting of Republicans. This would be justifiable if a.) Republicans had destroyed the website that needed fixing or b.) predicted that nobody would sign up for the program in the first place. Neither condition holds, of … [Read more...] about Jay Cost: The Conservative Case Against Obamacare: A Restatement